CÁMARA REAL | TELEMADRID: El Rey comprueba los avances de la tecnología en la salud
El Rey visita el Mobile Wold Congress donde comprueba los avances de la tecnología en la salud. Allí se reencuentra con Samuel Sánchez, que presenta sus nanorrobots.
El Rey visita el Mobile Wold Congress donde comprueba los avances de la tecnología en la salud. Allí se reencuentra con Samuel Sánchez, que presenta sus nanorrobots.
Experts in nanomedicine met yesterday, 5 March, to discuss the latest advances in the study, diagnosis and treatment of rare diseases. Nano Rare Diseases Day was organised once again to … Read more
This fourth workshop aims to bring together representatives from medical hospitals, pharma and spin-off companies, patient associations, and research groups to create an interactive panel discussion on rare diseases from … Read more
In a significant advancement for lab-on-chip technology, IBEC researchers in the frame of the European project BLOC, have demonstrated the first integration of a benchtop nuclear magnetic resonance (NMR) spectrometer … Read more
En el stand de Mobile World Capital Barcelona, una experiencia desarrollada conjuntamente con Nanobots Therapeutics muestra el potencial de los nanobots terapéuticos como nueva herramienta para el tratamiento de enfermedades como el cáncer. La empresa es una derivada del Institut de Bioenginyeria de Catalunya y de ICREA, y representa un paso adelante en la transferencia de investigación hacia la práctica clínica.
Three research projects led by IBEC researchers Xavier Rovira-Clavé, David Esporrín Ubieto and Aránzazu Villasante have been selected by the Spanish Association Against Cancer for its 2025 Grant Programme. The grant presentation ceremony, held in Barcelona today, recognised the momentum behind these initiatives, which range from advanced cell therapy platforms to smart nanomotors and innovative paediatric tumour treatment strategies.
Ref: TSTR – RJ // Deadline: 05/03/2026 –
Ref: Phd-PG // Deadline: 08/03/2026
Ref: PR-PG // Deadline: 05/03/2026
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Molecular Biology Institute of Barcelona (IBMB) provides the most detailed picture to date of NrdR — the master regulator of ribonucleotide reductases (RNRs) in bacteria. Researchers obtained the first detailed images of the complete NrdR protein structure and showed how changes in the shape and grouping of this protein affect the way it controls key processes inside the cell. The findings, recently published in International Journal of Biological Macromolecules, increase our understanding of how bacteria regulate the production of the molecular building blocks of DNA, a crucial aspect for both fundamental microbiology and the development of new antimicrobial strategies.